Table 1 Patient characteristics (n = 27)
\({\overline{\text{x}}}\) or n | SD or % | |
|---|---|---|
General | ||
Age (years) | 73 | ± 12 |
Female (n) | 14 | 52% |
Body mass index | 26.5 | ± 4.4 |
Barthel index (points) | 92 | ± 9 |
Clinical condition before intervention | ||
NYHA classification | 3.1 | ± 0.5 |
Left ventricular ejection fraction (%) | 42 | ± 13 |
Mitral valve insufficiency (grade) | 3.2 | ± 0.4 |
Logistic EuroSCORE I (%) | 32 | ± 20 |
Percutaneous intervention | ||
1 MitraClip™ (n) | 21 | 78% |
2 MitraClips™ (n) | 5 | 18% |
3 MitraClips™ (n) | 1 | 4% |
ASD occluder needed (n) | 4 | 15% |
Clinical condition after intervention and before CR | ||
Left ventricular ejection fraction (%) | 45 | ± 12 |
Mitral valve insufficiency (grade) | 1.0 | ± 0.5 |
Mean gradient mitral valve (mmHg) | 3.0 | ± 1.4 |
Most common comorbidities at start of CR | ||
Hypertension (n) | 25 | 93% |
Orthopaedic problems (n) | 19 | 70% |
Coronary artery disease (n) | 16 | 59% |
Atrial fibrillation (n) | 16 | 59% |
Renal insufficiency (n) | 11 | 41% |
Diabetes mellitus (n) | 5 | 18% |
Time | ||
Implantation to CR (days) | 16 | ± 13 |
Duration of CR (days) | 22 | ± 4 |